News
We have a French Bulldog approaching four years of age. We have been to several veterinarians trying to resolve his chronic ...
In January, the FDA released a warning letter about a new canine allergy drug called Zenrelia. The letter updated safety ...
ZTS reports better-than-expected first-quarter results as earnings and revenues surpass estimates. Management raises 2025 ...
ZTS' higher companion animal product sales are likely to have driven revenues in first-quarter 2025 in both the United States ...
Zoetis beats Q1 estimates with $1.48 EPS and $2.22 billion revenue, raises full-year forecast on strong demand for companion ...
Zoetis accelerates growth through high-margin companion animal drugs and strategic focus, supporting above-consensus EPS.
Guinness is already a survivor at just seven months, Loretta is the queen of couch cuddles, Pumbaa is the sweetest boy bonded ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
In addition to therapeutic dog foods and antihistamines, there are now two major medications vets can use, allowing them to avoid steroids. “Called Apoquel and Cytopoint that have been a game ...
In particular, it is almost impossible to buy the sought-after Propalin from the French company Vetoquinol (used for urinary incontinence in dogs) or Apoquel from the American Zoetis (designed for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results